Idi Insur (IDIN) AI Stock Analysis

• Market Cap: 2.87B
• Dividend Yield: 762.94%
• Average Volume (3M): 39.08K
• Price to Earnings (P/E): 9.6
• Beta (1Y): 1.26
• Revenue Growth: 25.90%
• EPS Growth: 68.30%
• Country: IL
• Employees: 1,693
• Sector: Financial
• Sector Strength: 74
• Industry: Insurance - Diversified
• EPS (TTM): 614.00
• Shares Outstanding: 14,773,255
• 10 Day Avg. Volume: 57,774
• 30 Day Avg. Volume: 39,084
• PEG Ratio: 0.69
• Price to Book (P/B): 2.75
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 18.67
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 70 Outperform
• Price Target: 22,187.00 ▲(14.31%Upside)

Idi Insur's strong financial performance, particularly robust revenue growth and profitability, heavily influence the overall score. The favorable valuation enhances its appeal despite mixed technical signals, providing a balanced investment case.

Idi Insur Business Overview & Revenue Model

Company Description

I.D.I. Insurance Company Ltd. provides insurance products and services to individuals and corporate customers in Israel. It offers life, health, personal accidents, business, car, home, travel, mortgage, and motorcycle insurance, as well as professional liability insurance for lawyers; and direct financing and savings plans. The company was founded in 2006 and is headquartered in Petah Tikva, Israel.

How the Company Makes Money

Idi Insur generates revenue primarily through the collection of premiums from its insurance policyholders. These premiums are calculated based on risk assessments and are paid by customers on a regular basis, typically monthly or annually. In addition to premium income, the company invests these collected premiums in various financial instruments such as stocks, bonds, and real estate to generate additional income. Idi Insur also partners with other financial institutions and brokers to expand its distribution network and enhance its product offerings, thereby increasing its customer base and revenue potential. The company's earnings are significantly influenced by its underwriting efficiency, investment performance, and the effective management of claims expenses.

Idi Insur Financial Statement Overview

Summary

Idi Insur shows strong financial health with solid revenue growth and profitability. The balance sheet indicates a balanced financing approach, though leverage requires monitoring. Cash flow management has room for improvement, but operational cash generation remains robust.

Income Statement

Idi Insur has demonstrated a solid revenue growth trajectory with significant improvement in net income over the years, indicating strong operational performance. The gross profit margin is robust, reflecting effective cost management. However, the EBIT margin saw fluctuations due to varying operational efficiencies in different years.

Balance Sheet

The company's equity ratio indicates a well-balanced use of equity to finance assets, although the debt-to-equity ratio suggests a moderate level of leverage that could be a risk if not managed properly. The return on equity is healthy, showing good returns generated on shareholders' investments.

Cash Flow

Cash flow performance is mixed, with fluctuations in free cash flow growth. While operating cash flow to net income ratio shows positive cash generation from operations, the free cash flow to net income ratio indicates some constraints in converting earnings into free cash flow due to capital expenditures.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.52B	3.52B	2.73B	2.20B	2.16B	2.12B
Gross Profit	3.39B	3.06B	2.73B	2.20B	2.16B	2.12B
EBITDA	554.29M	497.95M	287.43M	185.27M	365.80M	375.97M
Net Income	296.87M	257.08M	139.21M	84.44M	201.20M	207.32M
Balance Sheet
Total Assets	5.98B	7.13B	6.44B	6.20B	6.30B	6.07B
Cash, Cash Equivalents and Short-Term Investments	228.11M	98.45M	257.87M	253.20M	705.96M	360.00M
Total Debt	0.00	583.86M	541.92M	69.88M	73.24M	578.78M
Total Liabilities	4.83B	6.14B	5.52B	5.35B	5.44B	5.26B
Stockholders Equity	1.15B	988.82M	926.00M	855.52M	862.16M	814.09M
Cash Flow
Free Cash Flow	169.39M	48.20M	95.93M	-211.78M	372.32M	53.38M
Operating Cash Flow	273.67M	143.42M	193.65M	-130.23M	456.43M	129.50M
Investing Cash Flow	-99.53M	-91.94M	-97.65M	-79.02M	-98.57M	-73.86M
Financing Cash Flow	-271.57M	-211.99M	-93.05M	-244.47M	-11.54M	-73.28M

Idi Insur Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 19410.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:IDIN, the sentiment is Positive. The current price of 19410 is below the 20-day moving average (MA) of 20696.00, above the 50-day MA of 19393.93, and above the 200-day MA of 15515.76, indicating a neutral trend. The MACD of -87.38 indicates Positive momentum. The RSI at 50.02 is Neutral, neither overbought nor oversold. The STOCH value of 49.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:IDIN.

Idi Insur Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AYAL	74 Outperform	1.54B	10.03		195.28%	22.57%	73.32%
IDIN	70 Outperform	2.87B	9.62		762.94%	25.90%	68.30%
CLIS	70 Outperform	13.40B	12.29		224.27%	―	―
MGDL	70 Outperform	10.77B	14.02		47.79%	-16.50%	29.61%
Sector *	68 Neutral	$17.10B	11.62	9.70%	3.86%	11.32%	-7.37%
HAHRF	―	$6.65B	6.29	12.96%	1.00%	―	―
MMHD	68 Neutral	18.72B	15.22		233.31%	-2.35%	80.26%

Idi Insur Corporate Events

Idi Insur Faces Class Action Over Alleged Geographical Discrimination

Idi Insur is facing a class action lawsuit filed in the Be’er Sheva District Court over allegations of discriminatory practices based on geographical location. The lawsuit accuses the company of imposing additional security requirements and higher premiums on insurance candidates from certain areas without statistical justification. The claimant seeks financial compensation, an injunction against the alleged practices, and a declaration that such discrimination is invalid.